Friedman SL. Liver fibrosis from bench to bedside. J Hepatol, 2003, 38, S38-53.
Brondex A, Arlès F, Lipovac AS, et al. Cirrhotic car-diomyopathy : A specific entity. Ann Cardiol Angiéiol, 2012, 61, 99-104.
Zard EM, Abbate A, Zardi DM, et al. Cirrhotic Car-diomyopathy. J Am Coll Cardiol, 2010, 56, 539-549.
Baik SK, Fouad TR, Lee SS, et al. Cirrhotic Cardio-myopathy. Orph J Rare Diseases, 2007, 2, 15.
Al-BusafiSA, McNabb-Baltar J, Farag A, et al. Cli-nical manifestation of Portal Hypertension. Int J Hepa-tol, 2012, article ID 203794.
Wiest R, Shah V, Sessa WC, et al. NO overpro-duction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats. Am J Physiol, 1999, 276, G1043-51.
Sawant P, Vashishtha C, Nasa M. Management of Cardiopulmonary Complications of Cirrhosis. Int J Hepatol, 2011, article ID 280569.
Raval Z, Harinstein ME, Skaro AI, et al. Cardiovas-cular Risk Assessment of the Liver Transplant Candi-date. J Am Coll Cardiol, 2011, 58, 223.
Lee SS. Cardiac abnormalities in liver cirrhosis. West J Med, 1989, 151, 530-535.
SeirafiM, Spahr L. La cardiomyopathie cirrhotique. Rev Méd Suisse, 2009, 5, 1725-1731.
Wong F. Cirrhotic cardiomyopathy. Hepatol Int, 2009, 3, 294-304.
Alqahtani, Fouad TR, Lee SS. Cirrhotic cardiomyo-pathy. Sem Liver Ds, 2008, 28, 59-69.
Ma Z, Lee SS, Meddings JB. Effects of altered cardiac membrane fluidity on beta-adrenergic recep-tor signalling in rats with cirrhotic cardiomyopathy. J Hepatol, 1997, 26, 904-912.
Caraceni P, Domenicali M, Bernardi M. The endo-cannabinoid system and liver diseases. J Neuroendo-crinol, 2008, 20, 47-52.
Liu H, Ma Z, Lee SS. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterol, 2000, 118, 937-944.
Liu H, Song D, Lee SS. Role of heme oxygenase-carbon monoxide pathway in pathogenesis of cirrhotic cardiomyopathy in the rat. Am J Physiol Gastrointest Liver Physiol, 2001, 280, G68-G74.
Zambruni A, Trevisani F, Caraceni P, et al. Cardiac electrophysiological abnormalities in patient withs cir-rhotis. J Hepatol, 2006, 44, 994-1002.
Torregrosa M, Aguadé S, Dos L, et al. Cardiac alte-rations in cirrhosis : Reversibility after liver transplan-tation. J Hepatol, 2005, 42, 68-74.
Cazzaniga M, Salerno F, Pagnozzi G, et al. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosys-temic shunt. Gut, 2007, 56, 869-875.
Kim MY, Baik SK, Won CS, et al. Dobutamine stress echocardiography for evaluating cirrhotic cardio-myopathy in liver cirrhosis. Korean J Hepatol, 2010, 16, 376-382.
Kaeankov K, Holland-Fischer P, Andersen NH, et al. Resting myocardial dysfunction in cirrhosis quantified by tissue doppler Imaging. Liver Int, 2011, 31, 534-540.
